Australian natural beauty brand Subtle Energies is optimistic that with changing regulations it will be able to expand its business and tap into the emerging trends in China.
Claims development must happen simultaneously with new product development to ensure beauty products stand up to scrutiny under EU law, says an expert cosmetic claims consultant.
The Indonesian beauty market one of South East Asia’s biggest opportunities, but despite the low barriers to entry via cross-border e-commerce, cosmetic companies must take note of the market’s set of unique challenges.
The European Chemicals Agency (ECHA) has displayed a very narrow view of the cosmetics and personal care industry in its proposal to restrict microplastics, underestimating the true value and complexity of the sector, says the director-general...
China’s has released a document detailing the animal testing exemptions for imported general use cosmetics, but experts say cosmetic companies will find themselves jumping through hoops to qualify for them
The mercury concentration in hair samples of skin lightening cosmetic users has been found to be three times higher than those who don’t use such products.
China is making momentous strides to remove the barrier of animal testing for imported cosmetics, but experts believe foreign companies will still face hurdles even if exemptions are granted.
China’s National Medical Products Administration has released two additional drafts detailing safety and classification requirements under the new Cosmetic Supervision and Administration Regulation (CSAR).
China has released two drafts supporting Cosmetic Supervision and Administration Regulation (CSAR), one of which specifies how it plans to improve the process of cosmetic registration and notification.
The Zhejiang government has published a document detailing plans develop its cosmetics development zone to boost its competitiveness among the international players.
Cannabis in beauty and personal care has mushroomed in recent years and created a growing need for raw material testing, but current solutions remain fraught with challenges, says Frost & Sullivan.
The European Commission will soon publish its final synopsis report and evaluation of findings from public, stakeholder and SME consultations on current EU assessment and management of endocrine disruptors.
Clarification on the rules regarding animal testing in China is expected to be issued in the next six months, following the publication of the recent Cosmetics Supervision and Administration Regulation (CSAR).
The Institute for In Vitro Sciences Inc (IIVS) believes the support from domestic cosmetic companies can help to further its cause to implement non-animal testing methods in China.
